🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to Sue MacLeman, who has served with distinction as MTPConnect’s Chair since 2018, and will now step down from the Board, but will continue to act as an advisor though the initial transition. 2/2

New Case Study: MTPConnect's Adelaide Intermediary Program is providing experienced insights, strategy & mentoring with CRC-P applications, to help progress SA’s start-up innovation along the pipeline towards clinical and commercial success . Read more: bit.ly/41ETbYS

Our Chair Hon. Jaala Pulford with Industry & Science Minister Ed Husic MP & Science & Technology Australia CEO Misha Schubert getting ready for the National Press Club Address for #SMP2023!

🎧NEW PODCAST 🎆150 episodes🎆 To celebrate, host Caroline Duell chats to our new Chair Hon. Jaala Pulford about her 14-year distinguished career, her passion for medical research & innovation & her mission to build on MTPConnect’s 7 years of success! 🎧bit.ly/3KBCCGx

🎧Stay tuned for a special podcast episode from the “Advancing the SABRE Alliance’ workshop held in Canberra recently. Bringing Australia’s biotech sector together with Defence & national security to capitalise on new opportunities to safeguard our country.

Kickstarting BioKorea23 #Hojubio with fabulous turnout for clinical trials symposium-great to join Austrade’s Julie Quinn and Southern Star Research’s David Lloyd to highlight Australia’s compelling clinical trials offer. And shoutout to Global Victoria for bringing us all together

Wonderful to chat with Central Pharmacy Logistics CEO Rima Darwiche here at BioKorea. Our warm congratulations on your 2023 Emerging Leadership Award from @biomelb – richly deserved! And glad to hear our #REDI supported Essential GMP training program through CBE worked so well for your business.

Great meeting today in Westwood, Los Angeles b4 the The MedTech Conference starts, with our chair @jaalapulford, CEO @studignam & MedTech Innovator CEO Paul Grand Paul Grand: exploring ways to build a commercially-focused medtech community on both sides of the Pacific.👍🇦🇺Delegation in US!

As the nation’s peak body for scientists, technologists, engineers and mathematicians, Science & Technology Australia urges a resounding ‘Yes’ vote in the October 14 referendum. You can show your support, volunteer and donate here: yes23.com.au/action #Yes23au #Yes23 Yes23

Vale Chuck Feeney, US businessman, philanthropist & friend to 🇦🇺 with an affinity for QLD & passion for medical research. With vision & generosity he helped establish powerhouse institutions Translational Research Institute, AIBN Research, Institute for Molecular Bioscience, Queensland Brain Institute, UQ. ‘Giving while living’ for better health!

Delighted to join my MTPConnect colleague Duncan for great discussions with the Asia Pac and Aust/NZ leadership teams of テルモ株式会社, Japan’s biggest medtech company. Committed to 🇦🇺, collaboration, innovation and medical product manufacturing.

The 6th season of the popular MTPConnect podcast is landing soon with more stories from the people behind Australia's innovative medtech, biotech & pharma sector. Find our show on Apple Podcasts & all good podcasting platforms. Don't forget to subscribe! bit.ly/3YVk4q6

Our MTPConnect event in Adelaide getting underway - the big Commonwealth funders are here to talk about access to capital to drive business growth.

Australian scientists have invented a high-tech device which could prevent millions from life-threatening heart attacks. It comes as a medical mega grant promises to accelerate local innovation. youtu.be/84m8yCHyT8o Jackie Quist #7NEWS

Great to see MTPConnect's Drew Bowskill, co-chair of AAMRNet connecting with AMR Action Fund CEO Henry Skinner at the World Antimicrobial Resistance Congress in Philadelphia. Promoting Australia’s increasing role in the fight against antimicrobial resistance & building links with international partners! 🌏

🚨AusBiotech & MTPConnect are partnering to deliver Australia’s first National Biotech & Medtech Development & Commercialisation Summit, in Canberra 19 Nov 2024... 🧵1/2 👉bit.ly/4gv63YQ

🎧 Omico Australia is giving 23K Australians with advanced cancers, free genomic profiling to match tumours with targeted treatments. We chat to Prof. David Thomas about saving lives, boosting cancer research & attracting more clinical trials to 🇦🇺bit.ly/4gDNSjC

The most significant week in global antimicrobial resistance policy has kicked off in New York with the United Nations General Assembly High Level Meeting on #AMR. MTPConnect 's Drew Bowskill co-chair AAMRNet is there - read his blog to find out more! bit.ly/3XUETmN

🚨Want to find out more about the funding application process for TTRA Drugs and Devices? Join the TTRA Information session webinar for Drugs & Devices! On 8 October 2024, 12.30 pm - 1.45 pm AEDT. 👉bit.ly/3Y1tQIJ

📢We have opened EOIs for the Targeted Translation Research Accelerator (TTRA) Drugs & Devices from 🇦🇺 SMEs keen to commercialise innovative medical products to address cardiovascular disease & diabetes complications. Up to $1.5M available. Closes 4 Nov. bit.ly/3XPL4HT